Conditions: Medulloblastoma
Interventions: Drug: Bridging Chemotherapy; Drug: Induction Cycles A1-A3; Drug: Induction Cycles A4-5; Drug: Consolidation Cycle A6; Drug: HIT-SKK Chemotherapy Cycles B1-3; Drug: Modified HIT-SKK Cycle B4-5
Sponsors: Nationwide Children’s Hospital; German Society of Paediatric Oncology and Hematology (GPOH gGmbH); Children’s of Alabama
Not yet **RECRUITING NOW**
Interventions: Drug: Bridging Chemotherapy; Drug: Induction Cycles A1-A3; Drug: Induction Cycles A4-5; Drug: Consolidation Cycle A6; Drug: HIT-SKK Chemotherapy Cycles B1-3; Drug: Modified HIT-SKK Cycle B4-5
Sponsors: Nationwide Children’s Hospital; German Society of Paediatric Oncology and Hematology (GPOH gGmbH); Children’s of Alabama
Not yet **RECRUITING NOW**
Source: View full study details on ClinicalTrials.gov
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
